Stay updated on Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial page.

Latest updates to the Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial page
- Check6 days agoChange DetectedThe Study Details page now includes posted results for NCT04285515, including MADRS change and CGI-S outcomes, and links to related publications.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference4%

- Check42 days agoChange DetectedUpdated version to v3.1.0 and removed sections on Placebos, Therapeutics, and Pharmaceutical Preparations, plus removed the old version label v3.0.2.SummaryDifference0.3%

- Check56 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, with no other core-content changes evident.SummaryDifference0.3%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%

- Check70 days agoChange DetectedThe web page has been updated to include a new facility name and specific locations in Russia, while also adding relevant publications related to lumateperone and bipolar disorder. Some previous location terms and references to the Russian Federation have been removed.SummaryDifference11%

Stay in the know with updates to Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial page.